Digitally Enabled Quality Improvement Intervention and LDL-C Control in Atherosclerotic Cardiovascular Disease

Study limitation reported by the research below: “No specific lipid-lowering drug was tested; the modality tag reflects the QI/digital intervention and general lipid-lowering therapy class rather than a single agent.”